These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 9455804

  • 1. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
    Festuccia C, Guerra F, D'Ascenzo S, Giunciuglio D, Albini A, Bologna M.
    Int J Cancer; 1998 Jan 30; 75(3):418-31. PubMed ID: 9455804
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug 30; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 3. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A, Bologna M.
    Int J Cancer; 2000 Feb 01; 85(3):407-15. PubMed ID: 10652434
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 01; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 5. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R, Biliran H, Sager R, Sheng S.
    Cancer Res; 2000 Sep 01; 60(17):4771-8. PubMed ID: 10987285
    [Abstract] [Full Text] [Related]

  • 6. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM, Hudson LG, Stack MS.
    Int J Cancer; 1998 Oct 29; 78(3):331-7. PubMed ID: 9766568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
    Shi C, Zhang N, Feng Y, Cao J, Chen X, Liu B.
    Cell Physiol Biochem; 2017 Oct 29; 41(4):1313-1324. PubMed ID: 28278500
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS.
    J Biol Chem; 2005 Oct 28; 280(43):36529-40. PubMed ID: 16127174
    [Abstract] [Full Text] [Related]

  • 14. The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostate tumor in SCID mice.
    Billström A, Hartley-Asp B, Lecander I, Batra S, Astedt B.
    Int J Cancer; 1995 May 16; 61(4):542-7. PubMed ID: 7759160
    [Abstract] [Full Text] [Related]

  • 15. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion.
    Festuccia C, Giunciuglio D, Guerra F, Villanova I, Angelucci A, Manduca P, Teti A, Albini A, Bologna M.
    Oncol Res; 1999 May 16; 11(1):17-31. PubMed ID: 10451028
    [Abstract] [Full Text] [Related]

  • 16. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator.
    Tiberio A, Farina AR, Tacconelli A, Cappabianca L, Gulino A, Mackay AR.
    Int J Cancer; 1997 Nov 27; 73(5):740-8. PubMed ID: 9398056
    [Abstract] [Full Text] [Related]

  • 17. Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation.
    Brunner G, Reimbold K, Meissauer A, Schirrmacher V, Erkell LJ.
    Exp Cell Res; 1998 Mar 15; 239(2):301-10. PubMed ID: 9521847
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta1 stimulates urokinase plasminogen activator system on prostate cancer cells.
    Unlü A, Leake RE.
    Int J Biol Markers; 2003 Mar 15; 18(2):147-51. PubMed ID: 12841684
    [Abstract] [Full Text] [Related]

  • 19. Urokinase induces receptor mediated brain tumor cell migration and invasion.
    MacDonald TJ, DeClerck YA, Laug WE.
    J Neurooncol; 1998 Dec 15; 40(3):215-26. PubMed ID: 10066093
    [Abstract] [Full Text] [Related]

  • 20. Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion.
    Jarrard DF, Blitz BF, Smith RC, Patai BL, Rukstalis DB.
    Prostate; 1994 Dec 15; 24(1):46-53. PubMed ID: 8290389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.